Stay updated on Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Sign up to get notified when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.

Latest updates to the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe record history now includes a new revision tag v3.6.3, updating the page's revision metadata and replacing the previous v3.6.2.SummaryDifference0.1%

- Check28 days agoChange DetectedA new revision entry v3.6.2 appears in the study history, replacing the previous v3.6.0 in the version list.SummaryDifference0.1%

- Check42 days agoChange DetectedThe latest version in the study record history indicates the recruitment status is not accepting participants, i.e., not currently recruiting, and is tagged as Revision: v3.6.0. The previous revision tag v3.5.5 has been removed.SummaryDifference0.3%

- Check49 days agoChange DetectedThe history now shows a new revision entry (v3.5.5) added to the history and the previous revision (v3.5.4) removed, updating the page's version history.SummaryDifference0.1%

- Check71 days agoChange DetectedA new site revision entry, v3.5.4, was added to the history. This reflects a platform update rather than an alteration to the study record content.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/release change rather than any edit to the study history details.SummaryDifference0.1%

Stay in the know with updates to Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.